recently proposed as an alternative to transplantation in the treatment of terminal heart
failure in the context of the lack of donors and raising number of patients on the waiting list.
Although these systems have proved their efficiency through a rigorous patient selection, the
complication rate remains high and experience shows that many of them are related to
haemodynamic modifications due to VAD implantation. Furthermore, VAD themselves have …